http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016148444-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a82962e22b6ae66d43ee1e8c950d93db
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C219-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C219-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222
filingDate 2016-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c8ff431b4cd5e757700725ec9132a9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_989d2017c1963967084597509e5acd04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d45777e87ac84a511b0a6030a7afff2
publicationDate 2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016148444-A1
titleOfInvention Novel desfesoterodine derivative, pharmaceutically acceptable salt thereof and pharmaceutical composition comprising same
abstract The present invention relates to a novel desfesoterodine derivative or a pharmaceutically acceptable salt thereof. More specifically, the present invention relates to a novel desfesoterodine derivative or a pharmaceutically acceptable salt thereof, which is biostable and is effective in the treatment of overactive bladder symptoms such as urinary incontinence, urinary urgency and urinary frequency, and a pharmaceutical composition comprising same for prevention and treatment of overactive bladder symptoms such as urinary incontinence, urinary urgency and urinary frequency.
priorityDate 2015-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014039216-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9411337-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013197082-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID536818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830

Total number of triples: 24.